Guideline for blood grouping and red cell antibody testing in pregnancy

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Transfusion Medicine

• Publication date

  2016-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tme.12299PMID 27074872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia

  2015cited by this paper
• Use of cffDNA to avoid administration of anti‐D to pregnant women when the fetus is RhD‐negative: implementation in the NHS

  2015cited by this paper
• Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis

  2015cited by this paper
• Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study

  2014cited by this paper
• Successful management of severe hemolytic disease of the fetus due to anti‐Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature

  2014cited by this paper
• BCSH guideline for the use of anti‐D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn

  2014cited by this paper
• Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.

  2014cited by this paper
• Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratories

  2013cited by this paper
• Human Blood Groups: Daniels/Human Blood Groups

  2013cited by this paper
• Anti‐Ge3 causes late‐onset hemolytic disease of the newborn: the fourth case in three Hispanic families

  2013cited by this paper
• Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility

  2013cited by this paper
• Pregnant women with red cell antibodies: Scottish National Clinical Guidance.

  2013cited by this paper
• Antenatal monitoring of anti‐D and anti‐c: could titre scores determined by column agglutination technology replace continuous flow analyser quantification?

  2013cited by this paper
• Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxis

  2012cited by this paper
• Guidelines for validation and qualification, including change control, for hospital transfusion laboratories *

  2012cited by this paper
• Guidelines for the Estimation of Fetomaternal Haemorrhage Working Party of the British Committee for Standards in Haematology, Transfusion Taskforce.

  2011cited by this paper
• Has anti‐D prophylaxis increased the rate of positive direct antiglobulin test results and can the direct antiglobulin test predict need for phototherapy in Rh/ABO incompatibility?

  2011cited by this paper
• A retrospective study of positive antibody screens at delivery in Rh-negative parturients

  2010cited by this paper
• Noninvasive fetal blood grouping: present and future.

  2010cited by this paper
• Risk factors for the presence of non‐rhesus D red blood cell antibodies in pregnancy *

  2009cited by this paper
• The international standard for epidermal growth factor (EGF): comparison of candidate preparations by in vitro bioassays and immunoassays. National Institute for Biological Standards and Control.

  2009cited by this paper
• Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities

  2009cited by this paper
• Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects

  2009cited by this paper
• Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study

  2008cited by this paper
• Effect of screening for red cell antibodies, other than anti‐D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands

  2008cited by this paper
• Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell‐free fetal DNA in maternal plasma

  2007cited by this paper
• Guideline for blood grouping and antibody testing in pregnancy

  2007cited by this paper
• Management of Pregnancies Complicated by Anti-E Alloimmunization

  2005cited by this paper
• Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity

  2004cited by this paper
• The 2004 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

  2004cited by this paper
• Human Blood Groups (2nd edn)

  2004cited by this paper
• Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn

  2004cited by this paper
• Routine anti-D prophylaxis for RhD-negative pregnant women

  2003cited by this paper
• Causes of fetal anemia in hemolytic disease due to anti‐K

  2003cited by this paper
• How concerned should we be about missing antibodies to low incidence antigens?

  2003cited by this paper
• A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.

  2003cited by this paper
• Pharmacokinetics of anti‐D IgG in pregnant RhD‐negative women

  2003cited by this paper
• The clinical significance of blood group antibodies

  2002cited by this paper
• Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis

  2001cited by this paper
• Antenatal antibody screening.

  2001influential reference
• Identification and quantification of anti‐D, ‐C and ‐G in alloimmunized pregnant women

  2001cited by this paper
• Anti‐E in pregnancy

  2000cited by this paper
• Quantitative determination of anti‐K (KEL1) IgG and IgG subclasses in the serum of severely alloimmunized pregnant women by ELISA

  2000cited by this paper
• Non-anti-D antibodies in red-cell alloimmunization.

  2000cited by this paper
• NONINVASIVE DIAGNOSIS BY DOPPLER ULTRASONOGRAPHY OF FETAL ANEMIA DUE TO MATERNAL RED-CELL ALLOIMMUNIZATION

  2000cited by this paper
• A prospective study of routine antenatal enzyme antibody screening demonstrates lack of clinical value in predicting haemolytic disease of the newborn

  1999cited by this paper
• Management of pregnancies complicated by anti-Kell isoimmunization.

  1999cited by this paper
• Is a third-trimester antibody screen in Rh+ women necessary?

  1999cited by this paper
• Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study

  1999cited by this paper
• Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.

  1998cited by this paper
• Anti‐U and haemolytic disease of the fetus and newborn

  1998cited by this paper
• Consequences for fetus and neonate of maternal red cell allo-immunisation

  1998cited by this paper
• Haemolytic disease of the fetus and newborn due to anti‐Fya and the potential clinical value of Duffy genotyping in pregnancies at risk

  1997cited by this paper
• Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratories

  1996cited by this paper
• Quantification of anti‐c in haemolytic disease of the newborn

  1995cited by this paper
• Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group.

  1994cited by this paper
• A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy

  1993cited by this paper
• Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation.

  1992cited by this paper
• Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.

  1982cited by this paper
• Turnover rate of anti-D IgG injected during pregnancy.

  1982cited by this paper
• British Committee for Standards in Haematology

  1969cited by this paper
• Human Blood Groups

  1951cited by this paper

• Is fetal RHD genotyping without fetal markers still unacceptable in D-alloimmunized RhD negative pregnant women?

  2025cites this paper
• The prevalence and timing of seroconversion during pregnancy—A retrospective study to enable safe transfusion

  2025cites this paper
• The contemporary management of haemolytic disease of the fetus and newborn

  2025cites this paper
• Prevalence and clinical implications of unexpected red blood cell antibodies in a tertiary care hospital in Sri Lanka

  2025cites this paper
• Anti‐Ce in haemolytic disease of the foetus and newborn

  2025cites this paper
• Haematology of pregnancy

  2025cites this paper
• Alloanti‐Hy in antenatal patients: A multi‐case review

  2025cites this paper
• Phenotypic Frequency of ABO, RH1, and Kell Blood Group Antigens in Blood Donors from Southern Chile

  2025cites this paper
• Novel proof of concept assay for rapid, simplified non-invasive fetal RhD screening

  2025cites this paper
• Management of pregnancies with anti-K alloantibodies and the predictive value of anti-K titration testing.

  2024cites this paper
• Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States

  2024cites this paper
• How I manage pregnant patients who are alloimmunized to RBC antigens.

  2024cites this paper
• Red Blood Cell Alloimmunization in Pregnancy: A Review of the Pathophysiology, Prevalence, and Risk Factors

  2024cites this paper
• Guidelines for the specification, implementation and management of IT systems in hospital transfusion laboratories: A British Society for Haematology Guideline

  2024cites this paper
• Neonatal screening of ABO/RhD blood group and direct antiglobulin Coombs test. Experience of a single institution.

  2024cites this paper
• Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?

  2024cites this paper
• Aligning Minor Blood Groups Amid RhD Incompatibility: A Case Analysis

  2024cites this paper
• Potential of a Second Screening Test for Alloimmunization in Pregnancies of Rhesus-positive Women: A Swedish Population-based Cohort Study

  2024cites this paper
• Alloantibody Identification: The Importance of Temperature, Strength Reaction and Enzymes—A Practical Approach

  2024cites this paper
• Analysis of Specificity and Distribution Characteristics of Red Blood Cell Irregular Antibodies.

  2023cites this paper
• Comparison of automated solid phase versus manual saline indirect antiglobulin test methodology for non‐ABO antibody titration: Implications for perinatal antibody monitoring

  2023cites this paper
• Anemia among pregnant women a major concern for achieving universal health coverage

  2023cites this paper
• Antibody Titers in Transfusion Medicine: A Critical Reevaluation of Testing Accuracy, Reliability, and Clinical Use.

  2023cites this paper
• Clinical value of combination detection of direct antiglobulin test and serum albumin globulin ratio in severe hyperbilirubinemia caused by ABO hemolytic disease of the newborn

  2023cites this paper
• Significance of red cell alloantibodies other than anti-D during pregnancy and their effect on the newborn: A case series

  2023cites this paper
• Immunohematological testing and transfusion management of the prenatal patient.

  2023cites this paper
• The effectiveness of the organization and specific prevention of Rh-conflict during pregnancy

  2023cites this paper
• Neonatal hemolytic disease: How should we use indirect and direct antiglobulin tests?

  2023cites this paper
• Clinical value of combination detection of direct antiglobulin test and serum albumin globulin ratio in severe hyperbilirubinemia caused by ABO hemolytic disease of the newborn: A single-center retrospective analysis

  2022cites this paper
• TRANSFUSION PRACTICES IN OBSTETRICS AND GYNAECOLOGY

  2022cites this paper
• Immunohematology testing using umbilical cord blood: review of the literature, survey of practice and guidance development

  2022influential citation
• A case of severe hemolytic disease of newborn due to alloimmunization in primigravida.

  2022cites this paper
• A case report on non-D HDFN: Highlighting the role of antibody screening in RhD positive antenatal women

  2022influential citation
• KẾT HỢP THANG ĐIỂM SPESI VÀ CRP-HS TRONG TIÊN LƯỢNG TỬ VONG 30 NGÀY TRÊN BỆNH NHÂN TẮC ĐỘNG MẠCH PHỔI CẤP

  2022cites this paper
• KHẢO SÁT VÀ ĐỊNH DANH KHÁNG THỂ BẤT THƯỜNG Ở NHỮNG SẢN PHỤ CÓ TIỀN CĂN SẢY THAI

  2022cites this paper
• Identification and management of fetal anemia due to hemolytic disease

  2022cites this paper
• Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western India

  2022cites this paper
• Reassessment of Critical Anti-D Antibody Titer in RhD Alloimmunized Antenatal Women.

  2022cites this paper
• Irregular erythrocyte antibodies among antenatal women and their neonatal outcome at a tertiary care hospital in Northern India

  2021cites this paper
• Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal‐foetal incompatibility: A retrospective cohort study

  2021influential citation
• Immunohaematological conundrums in obstetrics from transfusion services viewpoint in Armed Forces setup.

  2021cites this paper
• Management and clinical consequences of red blood cell antibodies in pregnancy: A population‐based cohort study

  2021cites this paper
• Haemolytic disease of the fetus and newborn: do not miss a positive maternal antierythrocyte antibody screen

  2021cites this paper
• Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti‐D prophylaxis: A retrospective nationwide cohort study

  2021cites this paper
• Critical value reporting of direct antiglobulin testing in newborns: No discernable pattern

  2021cites this paper
• Is it necessary to add the eluate testing to the direct antiglobulin test to improve the detection of maternal erythrocyte alloantibodies?

  2021cites this paper
• High prevalence of weak D type 42 in a large‐scale RHD genotyping program in the province of Quebec (Canada)

  2021cites this paper
• Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.

  2021cites this paper
• Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.

  2021cites this paper
• Time to be proactive about passive D: Distinguishing anti‐D alloimmunisation from RhIG

  2021cites this paper
• Survey of newborn direct antiglobulin testing practice in United States and Canadian transfusion services

  2021cites this paper
• Prognostic Significance and Prevalence of IgG Subtypes in Rh Haemolytic Disease of Fetus and Newborn

  2021cites this paper
• Prediction of anemia at delivery

  2021cites this paper
• Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study

  2020influential citation
• Alloimmunization in Pregnancy

  2020cites this paper
• A multi‐centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice

  2020cites this paper
• Monitoring of prenatal patients using a combined antibody titre for Rh and non‐Rh antibodies

  2020influential citation
• Intraoperative cell salvage as part of a blood conservation strategy in an obstetric population with abnormal placentation at a large Irish tertiary referral centre: an observational study

  2020cites this paper
• Red cell alloimmunization: A 2020 update

  2020cites this paper
• A Japanese multi‐institutional collaborative study of antigen‐positive red blood cell (RBC) transfusions in patients with corresponding RBC antibodies

  2020cites this paper
• Minor blood group incompatibility due to blood groups other than Rh(D) leading to hemolytic disease of fetus and newborn: a need for routine antibody screening during pregnancy.

  2020cites this paper
• Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka

  2020cites this paper
• Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions.

  2020cites this paper
• Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study

  2020cites this paper
• Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation

  2020cites this paper
• Implementation of a Standardized Prenatal Testing Protocol in an Integrated, Multihospital Health System.

  2020cites this paper
• Antenatal screening practices in the WHO European Region: a mixed methods study

  2020cites this paper
• Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn.

  2020cites this paper
• Donor oocyte‐facilitated reproduction: Time to revisit the BSH antenatal guidelines?

  2020cites this paper
• Immunohematology and Blood banking: Principles and Practice

  2020cites this paper
• References

  2020cites this paper
• Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti‐D in pregnancy

  2020influential citation
• Distribution of antenatal alloimmunization in the southern districts of West Bengal and its significant associated factor

  2020cites this paper
• A RETROSPECTIVE STUDY ON THE FREQUENCY OF RH NEGATIVE BLOOD GROUP IN PREGNANT WOMEN

  2020cites this paper
• A retrospective study of the added value of parallel titers compared with serial titers

  2019cites this paper
• UK guidelines on the management of iron deficiency in pregnancy

  2019cites this paper
• Prevalence and obstetric outcome of women with red cell antibodies in pregnancy at the Leeds Teaching Hospitals NHS Trust, West Yorkshire, England.

  2019cites this paper
• Rh immune globulin: an interfering substance in compatibility testing

  2019cites this paper
• Rhesus-Negative Mother

  2019cites this paper
• A RESEARCH TO ASSESS THE RH-NEGATIVE FREQUENCY IN THE PREGNANT CASES REGARDING DISTRIBUTION OF RHESUS BLOOD GROUPS AND PARITY

  2018cites this paper
• Эффективность организации и активизация научно-исследовательской работы преподавателей в УГЛТУ

  2018cites this paper
• Antikörpertitration bei der hämolytischen Erkrankung des Fetus und Neugeborenen – State of the Art

  2018influential citation
• Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion

  2018influential citation
• Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review

  2018cites this paper
• Maternal sickle cell disease and twin pregnancy: a case series and review of the literature

  2018cites this paper
• Anti‐D quantification in relation to anti‐D titre, middle cerebral artery Doppler measurement and clinical outcome in RhD‐immunized pregnancies

  2018cites this paper
• Bombay phenotype (Oh) and high‐titer anti‐H in pregnancy: two case reports and a review of the literature

  2018cites this paper
• Red Blood Cell Alloimmunization in the Pregnant Patient.

  2018cites this paper
• Frequency of Red Cell Alloantibodies in Pregnant Females of Navsari District: An Experience that Favours Inclusion of Screening for Irregular Erythrocyte Antibody in Routine Antenatal Testing Profile

  2018cites this paper
• Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post‐partum period: NATA consensus statement

  2018cites this paper
• A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: the SALVO (cell SALVage in Obstetrics) trial.

  2018cites this paper
• The incidence and outcome of clinically significant antibodies detected in Rhesus‐D positive pregnant women of the Northern Territory

  2018cites this paper
• Haematological Problems in Pregnancy

  2018cites this paper
• Anti‐D in a mother, hemizygous for the variant RHD*DNB gene, associated with hemolytic disease of the fetus and newborn

  2017cites this paper
• Cell salvage and donor blood transfusion during cesarean section: A pragmatic, multicentre randomised controlled trial (SALVO)

  2017cites this paper
• Cell Salvage and Donor Blood Transfusion during Caesarean Section:

  2017cites this paper
• University of Birmingham Cell Salvage and Donor Blood Transfusion during Caesarean Section:

  2017cites this paper
• Prevalence of maternal alloantibodies in a large teaching hospital and their impact on outcomes of fetuses/neonates

  2017cites this paper
• Expanding access to Transfusion Medicine and improving practice: guidelines, patient blood management, protocols and products

  2017cites this paper
• Red cell antibodies – clinical significance or just noise?

  2017cites this paper